Geistlich Clinical Science and Education: Learn More Today!

Skip to content

GEM 21S^®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More

SOLUTIONS

Bone Substitutes
Membranes
- Geistlich Bio-Gide^®
- RPM™
Matrices
- Geistlich Fibro-Gide^®
- Geistlich Mucograft^®
Bone Harvesting
- Instruments
3D Titanium Scaffold
- Yxoss CBR^®
Membrane Fixation
- MC Bio Supertack
Growth Factors
- GEM 21S^®

DISCOVER

Product Support
Young Professionals
Geistlich MyGuide
Geistlich Guarantee
Geistlich Knowledge Bites Program
Newsroom

LEARN

Events
Resources
Therapeutic Areas

Account

Search For:

Geistlich is dedicated to the continuing education of our clinician partners. Whether in person or virtual, our mission is to increase the knowledge of regenerative dentistry. We look forward to partnering with you on your journey and growing with you as a clinician.

1400+

Publications

700+

live events & courses
over the last 4 years

16000+

attendees from
educational events

Upcoming Events

Middle Atlantic Society OMS (MASOMS) Fall Meeting

October 29, 2024

Turf Valley Resort | Ellicott City, MD

Oct

29

110th American Academy of Periodontology Annual Meeting (AAP) 2024

October 31, 2024 - November 3, 2024

San Diego, CA

Oct

31

Full Spectrum Zygomatic and Pterygoid Implant

November 6, 2024 - November 9, 2024

Orlando, FL

Nov

6

Clinical Resources

Use the search and filter form below to find informative clinical content by format, therapeutic areas, or product.

Therapeutic Areas
- Extraction Socket Management(27)
- Major Bone Augmentation(35)
- Minor Bone Augmentation(23)
- Miscellaneous(1)
- Peri-Implantitis(6)
- Periodontal Regeneration(11)
- Sinus-Floor Elevation(6)
- Soft-Tissue Regeneration(58)
Products
- Geistlich Bio-Gide Compressed®(2)
- Geistlich Bio-Gide Shape®(1)
- Geistlich Bio-Gide®(56)
- Geistlich Bio-Oss Collagen®(24)
- Geistlich Bio-Oss Pen®(1)
- Geistlich Bio-Oss®(67)
- Geistlich Fibro-Gide®(37)
- Geistlich Mucograft®(25)
- Geistlich Mucograft® Seal(4)
- GEM 21S®(7)
- Micross(2)
- RPM™(2)
- Safescraper Twist(3)
- vallomix™(5)
- vallos®(9)
- vallos®f(2)
- Yxoss CBR®(15)

Found 130 Results

A mid-facial incision was made, with the intent to preserve the minimal keratinized tissue that was available, as well as vertical incisions along the line angles of the canines to reflect a partial thickness flap.

Platelet-rich fibrin clots were formed by centrifugation. The leukocyte-PRF (L-PRF) was extracted, and the L-PRF was used to hydrate Geistlich Mucograft®

Geistlich Mucograft® and PRF stabilized via glycolon sutures.

Clinical situation at three-week follow-up.

Occlusal view at twelve-month follow-up.

Frontal view at twelve-month follow-up.

1 - Thin mucosal tissue over implant #7 creating an unesthetic appearance.

2 - Occlusal view of #7 reveals buccal soft-tissue defects.

3 - Augmentation of the soft-tissue on two implant sites, #7 and #10, using a conventional full thickness flap with vertical releasing incisions on site #7 and an envelope flap on site #10.

4 - Geistlich Fibro-Gide® is split into two 3mm thick matrices to be used in both sites, hydrated with sterile saline and trimmed to the defect dimensions.

5 - Geistlich Fibro-Gide® is secured to the periosteum apically and the interproximal papillae with 5-0 chromic gut sutures.

6 - Passive closure of the flap achieved with 6-0 vicryl sutures.

7 - 1 week post-surgery reveals uneventful healing with maintenance of tissue volume.

8 - Buccal view at 8 weeks reveals uneventful healing with maintenance of tissue volume.

9 - Occlusal view at 8 weeks post-surgery.

1 - Large horizontal and vertical bone defect in region 5-12; deficit emerging from many years of wearing mucosa-supported dentures.

2 - 3-D design including 3-D model, grafting volume, Yxoss CBR® and implants.

3 - 3-D Design including 3-D model and Yxoss CBR®.

4 - Initial clinical situation before opening of the soft tissue.

5 - Presentation of bony situs with a full-thickness flap (ridge incision).

6 - Titanium scaffold filled with 100% Geistlich Bio-Oss® and placed onto bone defect. Fixation performed with 4 mini-screws in the buccal area.

7 - Soft tissue situation after 6 months of healing.

8 – Careful separation of Yxoss CBR® into two parts at predetermined breaking points (Easy Removal Design®). Pilot drill performed through built-in holes according to backward planning principle.

9 - 4 implants placed in positions 5, 7, 10 and 12 to support the prosthesis. Bleeding out of the bone shows a good vascularization.

10 - Panoramic X-ray 6 months after the augmentation. In the meantime, 4 additional implants have been placed in the lower jaw.

1 - Preoperative radiograph depicting the severe bony atrophy in the posterior mandible.

2 - Fixation of the pre-formed osteosynthesis plate with miniscrews.

3 - Augmentation with autologous bone harvested from the angular region of the mandible and mixed with Geistlich Bio-Oss®.

4 - The grafted site including the osteosynthesis plate is covered with Geistlich Bio-Gide® and the tensile collagen membrane is pinned down. Thus, the augmented site is accurately covered and stabilized.

5 - In order to obtain primary wound closure, a double-layered suturing technique is used by combining a horizontal internal mattress and a coronal single stitch technique.

6 - Implants are inserted 6 months after augmentation and the healing abutments are connected to the implants.

7 - Lateral view of the final prosthetic restoration 6 months after implant placement.

8 - Intraoral radiograph 15 months after augmentation procedure showing a stable bony situation.

Page 3 of 11

Let's Stay Connected. (Enter Email) *

Contact

Geistlich Pharma North America Inc.
400 Alexander Park Drive, Suite 302
Princeton, NJ 08540

Customer Care Toll-free 855-799-5500
[email protected]

Help

Disclaimer
Shipping and Returns
Privacy Policy

Account

Login / Create Account

Company

Geistlich Pharma North America Inc.
Contact

These product(s) and promotion(s) are ONLY available within the North American Dental Markets (US & Canada). Promotions may vary in Canada and Puerto Rico. Please consult our exclusive Canadian distribution partner, HANSAmed Limited, for more details.

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.

© 2011 - 2024 Geistlich Pharma North America, Inc.